http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-87822-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aeeae3a1e9c2f6b4db133adad89691b1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54
filingDate 2004-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8c6c93015ee5815830a649acdde9585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4dfc8758fb787b040e34e0c7f03a3d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_314a4568ac21ac0e87edf72ae723a0d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f9b0932325d6cc6a8dc82c55eee36ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_502a6e9e1fb0c8a720fc8077b178c756
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e6fcbaf75c63ef342bbf01bb341e191
publicationDate 2009-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-87822-C2
titleOfInvention NAPHTHILENE DERIVATIVES AS P450 CYTOCHROME INHIBITORS
abstract Compounds of formula (I) and their pharmaceutically acceptable salts, for which n1, n2, n3, n4, G, Q, Z, R, R, R, R, R, R, and R are defined in the description, inhibit the cytochrome P450RAI enzyme and are used for treatment and/or prevention of various diseases and conditions that can be treated with retinoids and natural retinoic acid. Compounds of formula (I) and their pharmaceutically acceptable salts, for which n1, n2, n3, n4, G, Q, Z, R, R .
priorityDate 2003-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30381
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID154985
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID486804
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID450614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145826768
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100061805
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID539047
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554119
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13082

Total number of triples: 40.